Elsubrutinib
BTK Inhibitor (covalent; selective)
- CAS
- 1643570-24-4
- Formula
- C17H19N3O2
- Mol. weight
- 297.36 g/mol
- Purity
- ≥99%
Added. View your enquiry →
Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.
AbbVie covalent BTK; combined with venetoclax for B-cell malignancies. BTK + BCL-2 combination approach
Target class: BTK inhibitors
Research areas: Lymphoma, Solid Tumors
Related compounds
| SMILES | C=CC(=O)N1CCC[C@H](C1)C2=C3C=CNC3=C(C=C2)C(=O)N |
|---|---|
| InChIKey | UNHZLHSLZZWMNP-LLVKDONJSA-N |
